Investment News Daily · 2026-09-29
15 News Briefs · Multi-source Aggregation + AI Rewriting
Automatically crawled from Tonghuashun and Eastmoney by cron at 08:00 Beijing time daily, with summaries rewritten by Doubao. For information aggregation only, does not constitute investment advice.
- The Reserve Bank of Australia raised interest rates by 25 basis points to 4.6%, warning of inflation risks while triggering fluctuations in local related asset prices
- Hengrui Pharma licensed HRS-1596 to Novo Nordisk for a fee, with an upfront payment of 300 million USD and a total transaction value of up to 2.6 billion USD
- Toyota’s production and sales declined for the second consecutive month in August, and the total number of signed overseas stores of Chabaidao has exceeded 130
Tonghuashun 24/7
Australian 3-year Treasury bond yield narrows decline after RBA rate hike
2026/9/29 12:45:48
[Finance Brief] Related subjects include Australian 3-year Treasury bonds and the RBA’s interest rate hike policy. Core event: After the RBA’s rate hike took effect, the decline of the previously falling Australian 3-year Treasury bond yield narrowed significantly. This change is the bond market’s immediate response to this rate hike, indicating that the market has already priced in part of the rate hike expectations in advance. The subsequent trend of short-term Australian bonds will be anchored by the RBA’s policy guidance, and will also have a knock-on effect on the Australian dollar exchange rate and short-term cross-border capital flows.
Toyota’s sales and production decline for the second consecutive month in August
2026/9/29 12:38:41
[Summary] Toyota, the world’s largest automaker, saw its global production and sales decline year-on-year for the second consecutive month in August: global sales fell 6.4% year-on-year to 790,743 units, and production fell 5.9% year-on-year to 700,860 units. Core markets were a significant drag: sales in its largest market, the US, fell 4.4%, the Chinese market fell 22.8%, and sales in the Middle East plummeted 37.5%. Only the 9.1% sales growth in Japan’s domestic market failed to offset the overall downward pressure.
NYMEX platinum front-month contract falls more than 2%
2026/9/29 12:36:39
[Finance Brief] The related subject is the NYMEX (New York Mercantile Exchange) platinum front-month contract. The abnormal event is that the contract weakened during the session, with the decline expanding to more than 2%, last quoted at 1,709.2 USD per ounce. As a product with both industrial and precious metal attributes, this price drop will directly affect the valuation of precious metal positions, and at the same time have a spillover effect on the upstream pricing of related industrial chains such as automotive catalysts and jewelry consumption.
Chabaidao: Number of signed overseas stores exceeds 130
2026/9/29 12:33:11
On September 29, People’s Financial News learned from domestic tea beverage brand Chabaidao that the brand’s signed overseas stores have exceeded 130, covering 13 countries and regions. South Korea and Malaysia are key overseas markets it entered earlier, with the number of signed stores in the two regions now exceeding 50 and reaching 18 respectively. The relevant data shows the phased progress of Chabaidao’s overseas store expansion.
RBA raises interest rates by 25 basis points to 4.6%
2026/9/29 12:31:08
[Finance News Flash] The RBA recently announced a 25 basis point rate hike, raising the policy rate to 4.6%. This adjustment is in line with general market expectations, and the interest rate level hits a 13-year high since November 2011. This move will further push up the borrowing costs of local Australian residents’ mortgages and corporate financing, and may have a chain impact on the Australian dollar exchange rate, the valuation of Australian major asset classes, and the pricing of global commodity trade.
Hengrui Pharma: Licenses HRS-1596 to Novo Nordisk for a fee, with upfront payment of 300 million USD
2026/9/29 12:30:44
Hengrui Pharma announced that it has reached a licensing agreement with Novo Nordisk: it will grant the latter the exclusive global rights to develop, produce and commercialize its self-developed potential weekly GLP-1/GIP dual receptor agonist HRS-1596 outside of Greater China for a fee. The transaction has an upfront payment of 300 million USD, with a total value of up to 2.6 billion USD including milestone payments, and Hengrui can also receive sales royalties based on subsequent net sales.
Eastmoney 24/7
Shanghai expert team study confirms: Wearing hearing aids can reverse mild cognitive impairment in the elderly
2026/9/29 12:42:10
[News Summary] A study on elderly hearing and cognitive health led by the team of Professor Wu Hao from the Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine was recently published in the internationally authoritative journal JAMA Neurology. The study confirmed that among elderly people with moderate to severe hearing loss accompanied by mild cognitive impairment, the proportion of those whose cognition returned to normal within two years of standardly wearing hearing aids reached 15.34%, 6 times that of the control group that did not wear hearing aids. The value of hearing aids for cognitive intervention in the elderly has been authoratively verified.
Toyota’s sales and production decline for the second consecutive month in August
2026/9/29 12:38:13
Toyota, the world’s largest automaker, saw its global production and sales decline year-on-year for the second consecutive month in August: global sales fell 6.4% year-on-year to 790,743 units, and production fell 5.9% year-on-year to 700,860 units. Except for the 9.1% year-on-year sales growth in Japan’s domestic market, core markets generally underperformed: the Chinese market fell 22.8%, the largest single market the US fell 4.4%, and the Middle East region plummeted 37.5%. The downturn in overseas markets is the main reason for this decline.
Australian S&P/ASX 200 index gives up gains after central bank rate hike
2026/9/29 12:36:18
[Finance News Flash] Related subject is the Australian S&P/ASX 200 index. Trigger event: After the RBA announced its rate hike resolution, the index weakened rapidly, fully giving up all gains before the resolution was released. Impact: As of the late trading session, the index finally closed down 0.1%, reflecting the short-term suppression of the local equity market by the rate hike policy, and market sentiment fluctuated slightly under the impact of the tightening policy.
RBA raises rates by 25 basis points as expected, warns oil prices and AI demand push up inflation risks
2026/9/29 12:35:39
The RBA announced at its latest interest rate meeting that it will raise interest rates by 25 basis points as expected, raising the cash rate target to 4.60%. The central bank clearly indicated that upside inflation risks are gradually materializing: the conflict in the Middle East has pushed global oil prices significantly higher than the August forecast level, AI demand has driven the rapid rise in global technology product prices, coupled with domestic capacity pressure, there is great uncertainty in the subsequent inflation trend.
Hengrui Pharma: Licenses HRS-1596 to Novo Nordisk for a fee, potential total transaction value up to 2.6 billion USD
2026/9/29 12:32:30
Hengrui Pharma announced that it has reached an agreement with Novo Nordisk to grant the latter the exclusive global rights to develop, produce and commercialize its self-developed weekly GLP-1/GIP dual receptor agonist HRS-1596 outside of Greater China for a fee. The potential total transaction value of this deal is up to 2.6 billion USD, including a 300 million USD upfront payment and subsequent related milestone payments, making it one of the high-value licensing cases for domestic innovative drugs going overseas in recent years.
AUD/USD rises slightly by more than 10 pips in the short term
2026/9/29 12:31:16
[Finance Brief] Related subject is the AUD/USD exchange rate. Core event: The RBA released its latest interest rate resolution, raising rates by 25 basis points as expected, in line with previous general market expectations. Market impact: After the resolution was announced, AUD/USD rose slightly by more than 10 pips in the short term, with the latest quote at 0.7019. This policy adjustment, which was in line with expectations, did not trigger large abnormal fluctuations in the exchange rate.
Yahoo Finance
Ennis (EBF) Grows Sales but Earns Less. Are Legal Items Hiding a Better Business?
2026/9/23 09:52:26
The latest financial report disclosed by commercial printing company Ennis (ticker: EBF) listed on 美股 shows that current sales revenue achieved year-on-year growth, but net profit fell year-on-year due to drag from legal-related expenses. There is currently controversy in the market: whether the one-time legal items included in this financial report have concealed the improving trend of the company’s actual business operations, and its true profitability remains to be verified by subsequent data.
Strive CEO: Bitcoin Could ‘Go to Infinity’ as Dollar Debt Crisis Breaks
2026/9/23 09:51:00
The CEO of asset management firm Strive recently made a judgment on crypto assets, with the core subject being Bitcoin: if a US dollar debt crisis actually breaks out in the future, there is a possibility that Bitcoin’s price could “rise without an upper limit”. This view is a typical statement from the current crypto industry that regards Bitcoin as a hedge asset against US dollar credit risk. It has not been widely recognized by the market at present, and the relevant judgment is still highly controversial.
Westinghouse Air Brake (WAB) Signs $700 Million-Plus Rail Services Deal. Can Profits Grow?
2026/9/23 09:43:50
Rail transit equipment manufacturer Westinghouse Air Brake (ticker: WAB) recently signed a railway service order with a total value of more than 700 million USD, covering railway operation and maintenance and other related service categories. This large order provides potential increment for the company’s subsequent revenue and profit growth, however, the order delivery schedule and project cost control capability will still be the core factors determining whether its profit growth can be realized as scheduled.
Was this useful? A rating helps me pick the next topic.
Click a star to rate · Only anonymous fingerprint + timestamp stored